Lynch Syndrome (HNPCC) is a highly penetrant cancer-susceptibility syndrome characterized by an increased risk of various cancers, including colon, endometrial, stomach, and ovarian cancer. Mutations in two mismatch repair (MMR) genes, MLH1 and MSH2, are responsible for the majority of cases of Lynch Syndrome. However, the involvement of the MSH6 gene in this syndrome is becoming more lucid. The following paper addresses the prevalence of MSH6 mutations in a population at-risk for Lynch Syndrome and attempts to characterize the phenotype associated with these mutations.
Purpose:
To elucidate the involvement of MSH6 mutations in Lynch Syndrome and compare the resulting phenotype to individuals with MLH1 or MSH2 mutations.
Design and Methods:
Patients were recruited from the German HNPCC Registry if they were at-risk for Lynch Syndrome and mutations in MLH1 and MSH2 had been excluded.
Results:
Twenty-seven germline mutations in MSH6 were identified, representing 3.8% of the total registry and 14.7% of all families with DNA mismatch repair mutations. A predictive medicine product for hereditary uterine and colorectal cancer.
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